Results 1 to 10 of about 47,341 (232)

A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder [PDF]

Frontiers in Psychiatry, 2019
Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS).
Laura A. Potter, Danielle A. Scholze, Hazel Maridith B. Biag, Andrea Schneider, Andrea Schneider, Andrea Schneider, Yanjun Chen, Danh V. Nguyen, Akash Rajaratnam, Susan M. Rivera, Susan M. Rivera, Patrick S. Dwyer, Flora Tassone, Flora Tassone, Reem R. Al Olaby, Nimrah S. Choudhary, Maria J. Salcedo-Arellano, Randi J. Hagerman, Randi J. Hagerman   +18 more
doaj   +3 more sources

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder [PDF]

Frontiers in Genetics, 2020
Sertraline is one among several selective serotonin reuptake inhibitors (SSRIs) that exhibited improvement of language development in Autism Spectrum Disorder (ASD); however, the molecular mechanism has not been elucidated.
Reem Rafik Alolaby, Poonnada Jiraanont, Blythe Durbin-Johnson, Mittal Jasoliya, Hiu-Tung Tang, Randi Hagerman, Randi Hagerman, Flora Tassone, Flora Tassone   +8 more
doaj   +3 more sources

Adverse Drug Events on the Use of Sertraline in Clinical Studies: A Review

Jurnal Manajemen dan Pelayanan Farmasi, 2021
Major depressive disorder (MDD) and anxiety are known as a widespread public health problem treated with sertraline, a class of Selective Serotonin Reuptake Inhibitor (SSRI) drugs as first-line therapy.
Syahrul Hidayat, Irma M. Puspitasari
doaj   +1 more source

Are Treatment Preferences Relevant in Response to Serotonergic Antidepressants and Cognitive-Behavioral Therapy in Depressed Primary Care Patients? Results from a Randomized Controlled Trial Including a Patients' Choice Arm [PDF]

, 2010
Background Little is known about the influence of depressed patients' preferences and expectations about treatments upon treatment outcome We investigated whether better clinical outcome in depressed primary care patients is associated with receiving ...
Allgaier, Antje-Kathrin, Coyne, James, Hautzinger, Martin, Hegerl, Ulrich, Henkel, Verena, Kohnen, Ralf, Kramer, Dietmar, Mergl, Roland   +7 more
core   +13 more sources

SERTRALINE

Journal of Prescribing Practice, 2021
In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #sertraline
openaire   +2 more sources

Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism

EJNMMI Research, 2023
Background The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson’s disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we ...
Thomas E. H. Justesen, Per Borghammer, Joel Aanerud, Peter Hovind, Lisbeth Marner   +4 more
doaj   +1 more source

Peripartal treatment with low‐dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone

Physiological Reports, 2022
Women mobilize up to 10% of their bone mass during lactation to provide milk calcium. About 8%–13% of mothers use selective serotonin reuptake inhibitors (SSRI) to treat peripartum depression, but SSRIs independently decrease bone mass.
Celeste M. Sheftel, Luma C. Sartori, Emily R. Hunt, Robbie S. J. Manuel, Autumn M. Bell, Rafael R. Domingues, Lella A. Wake, Brandon R. Scharpf, Chad M. Vezina, Julia F. Charles, Laura L. Hernandez   +10 more
doaj   +1 more source

La2O3/Co3O4 nanocomposite modified screen printed electrode for voltammetric determination of sertraline [PDF]

Journal of the Serbian Chemical Society, 2020
La2O3/Co3O4 nanocomposite was synthesized and then used for the modification of screen-printed electrode (SPE) prior to the electrochemical determination of sertraline. A significant increment in peak current response was observed and peak potential also
Mohammadi Sayed Zia, Beitollahi Hadi, Rohani Tahereh, Allahabadi Hossein, Tajik Somayeh   +4 more
doaj   +1 more source

Pharmacogenetic Testing and Therapeutic Drug Monitoring Of Sertraline at a Residential Treatment Center for Children and Adolescents: A Pilot Study

INNOVATIONS in Pharmacy, 2022
Background: Sertraline is commonly prescribed to children for the treatment of anxiety and major depressive disorder and is metabolized in part by CYP2C19. While dosing recommendations based on CYP2C19 genotype exist, there is sparse data in children on
Katelyn France, David Ammend, Jacob Brown   +2 more
doaj   +1 more source

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia

Pharmacology Research & Perspectives, 2023
Augmentation of antipsychotic treatment with antidepressants represents a common and beneficial treatment strategy in patients suffering from schizophrenia. Combining clozapine and the selective serotonin reuptake inhibitor (SSRI) sertraline represents a
Arnim Johannes Gaebler, Ekkehard Haen, Nagia Ben Omar, Katharina Endres, Christoph Hiemke, Georgios Schoretsanitis, Michael Paulzen   +6 more
doaj   +1 more source